EUVIMEDEUVIMED entdecken
Crossref

Aegle marmelos neuroprotective potential in demyelination rat model through modulation of BDNF, GDNF, HSP-90 and HSP-60

Naheed Akhter, Nazma Nasir, Muhammad Irfan, Zunera Chauhdary

Inflammopharmacology · 2026-11 · 34 (11) · 7205-7230

DOI: 10.1007/s10787-026-02376-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammopharmacology, online erschienen am 02.09.2026. Verfasst von Naheed Akhter und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Government College University, Faisalabad, Pakistan. Hauptthemen laut MEDLINE: Neuroprotective Agents, Aegle, Plant Extracts, Demyelinating Diseases. Die Arbeit nennt 82 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis is a neurodegenerative disorder marked by axonal damage and demyelination; however, existing immunomodulatory treatments are ineffective requiring development of new therapeutic approaches. Aegle marmelos , a traditional medicinal plant rich in bioactive phytochemicals. This study examined the neuroprotective effects of Aegle marmelos ethanolic fruit extract (AME) in a cuprizone (CPZ)-induced MS rat model. AME GC–MS analysis and molecular docking analysis were performed. Sixty Wistar rats were divided into six groups: Control, MS model group (CPZ 0.2% in chow diet for 42 days), standard (fingolimod 15 mg/kg), and AME treatment groups (250, 500, and 750 mg/kg). Following 42 days of treatment neurobehavioural observation, biochemical analysis, neurotransmitters, gene expression for inflammatory cytokines, and histopathological examination were conducted. GC–MS analysis identifies neuroactive substances, including as fatty acids, phytosterols, and phenolic derivatives. Administration of AME reduced CPZ-induced behavioural deficits in a dose-dependent manner; the 750 mg/kg dose showed significant improvements in motor coordination, grip strength, spatial working memory ( p < 0.001). Pro-inflammatory mediators were markedly downregulated by RT-PCR, while antioxidant enzyme activities and neurotransmitters concentrations were also restored. AME treatment dose dependently restored serum level of BDNF, GDNF and decreased expression of HSP-90 and 60. AME treatment decreased the elevated expression of inflammatory cytokines, leukotrienes, prostaglandins and oxidative stress markers showing more pronounced antioxidant and anti-inflammatory potential. According to histopathological examination, AME-treated groups showed less demyelination and plaque formation with preserved neuronal architecture. By concurrently reducing oxidative stress, neuroinflammation, and promoting remyelination, these results show that AME exhibits strong neuroprotection. Multiple sclerosis is a neurodegenerative disorder marked by axonal damage and demyelination; however, existing immunomodulatory treatments are ineffective requiring development of new therapeutic approaches. Aegle marmelos, a traditional medicinal plant rich in bioactive phytochemicals. This study examined the neuroprotective effects of Aegle marmelos ethanolic fruit extract (AME) in a cuprizone (CPZ)-induced MS rat model. AME GC–MS analysis and molecular docking analysis were performed. Sixty Wistar rats were divided into six groups: Control, MS model group (CPZ 0.2% in chow diet for 42 days), standard (fingolimod 15 mg/kg), and AME treatment groups (250, 500, and 750 mg/kg). Following 42 days of treatment neurobehavioural observation, biochemical analysis, neurotransmitters, gene expression for inflammatory cytokines, and histopathological examination were conducted. GC–MS analysis identifies neuroactive substances, including as fatty acids, phytosterols, and phenolic derivatives. Administration of AME reduced CPZ-induced behavioural deficits in a dose-dependent manner; the 750 mg/kg dose showed significant improvements in motor coordination, grip strength, spatial working memory ( p < 0.001). Pro-inflammatory mediators were markedly downregulated by RT-PCR, while antioxidant enzyme activities and neurotransmitters concentrations were also restored. AME treatment dose dependently restored serum level of BDNF, GDNF and decreased expression of HSP-90 and 60. AME treatment decreased the elevated expression of inflammatory cytokines, leukotrienes, prostaglandins and oxidative stress markers showing more pronounced antioxidant and anti-inflammatory potential. According to histopathological examination, AME-treated groups showed less demyelination and plaque formation with preserved neuronal architecture. By concurrently reducing oxidative stress, neuroinflammation, and promoting remyelination, these results show that AME exhibits strong neuroprotection. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsAeglePlant ExtractsDemyelinating DiseasesMultiple SclerosisAnimalsRats, WistarBrain-Derived Neurotrophic FactorRatsMaleDisease Models, AnimalGlial Cell Line-Derived Neurotrophic FactorOxidative StressCuprizoneMolecular Docking SimulationDose-Response Relationship, Drug

Stichwörter der Autor:innen

Aegle marmelosCPZ-induced demyelinationMultiple SclerosisNeuroinflammationNeuroprotectionOxidative stressRemyelination

Substanzen

Neuroprotective AgentsPlant ExtractsBrain-Derived Neurotrophic FactorGlial Cell Line-Derived Neurotrophic FactorBdnf protein, ratGdnf protein, ratCuprizone

Autor:innen und Institutionen

  • Department of Biochemistry, Government College University, Faisalabad, Pakistan.
  • Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan.
  • Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan. zunerach@yahoo.com.

Zitieren

APA

Akhter, N., Nasir, N., Irfan, M., & Chauhdary, Z. (2026). Aegle marmelos neuroprotective potential in demyelination rat model through modulation of BDNF, GDNF, HSP-90 and HSP-60. Inflammopharmacology, 34(11), 7205-7230. https://doi.org/10.1007/s10787-026-02376-2

Vancouver

Akhter N, Nasir N, Irfan M, Chauhdary Z. Aegle marmelos neuroprotective potential in demyelination rat model through modulation of BDNF, GDNF, HSP-90 and HSP-60. Inflammopharmacology. 2026;34(11):7205-7230. doi:10.1007/s10787-026-02376-2

BibTeX
@article{Akhter2026,
  author = {Akhter, Naheed and Nasir, Nazma and Irfan, Muhammad and Chauhdary, Zunera},
  title = {Aegle marmelos neuroprotective potential in demyelination rat model through modulation of BDNF, GDNF, HSP-90 and HSP-60},
  journal = {Inflammopharmacology},
  year = {2026},
  volume = {34},
  number = {11},
  pages = {7205--7230},
  doi = {10.1007/s10787-026-02376-2}
}
Kostenlos starten →